Correlation Between Madrigal Pharmaceuticals and Cytodyn
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Cytodyn at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Cytodyn into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Cytodyn, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Cytodyn and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Cytodyn. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Cytodyn.
Diversification Opportunities for Madrigal Pharmaceuticals and Cytodyn
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Madrigal and Cytodyn is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Cytodyn in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytodyn and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Cytodyn. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytodyn has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Cytodyn go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Cytodyn
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 0.55 times more return on investment than Cytodyn. However, Madrigal Pharmaceuticals is 1.83 times less risky than Cytodyn. It trades about 0.06 of its potential returns per unit of risk. Cytodyn is currently generating about -0.01 per unit of risk. If you would invest 21,043 in Madrigal Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of 10,812 from holding Madrigal Pharmaceuticals or generate 51.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.6% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Cytodyn
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Cytodyn |
Madrigal Pharmaceuticals and Cytodyn Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Cytodyn
The main advantage of trading using opposite Madrigal Pharmaceuticals and Cytodyn positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Cytodyn can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytodyn will offset losses from the drop in Cytodyn's long position.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
| Cytodyn vs. Madrigal Pharmaceuticals | Cytodyn vs. Scpharmaceuticals | Cytodyn vs. Akero Therapeutics | Cytodyn vs. Cardiff Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |